Your browser doesn't support javascript.
loading
PP056. Placental growth factor is a better predictor of preterm birth than uterine or umbilical artery doppler in hypertensive disorders of pregnancy.
Stenczer, B; Molvarec, A; Gullai, N; Veresh, Z; Nagy, B; Rigo, J.
Afiliação
  • Stenczer B; First Dept. of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary.
  • Molvarec A; First Dept. of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary.
  • Gullai N; First Dept. of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary.
  • Veresh Z; First Dept. of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary.
  • Nagy B; First Dept. of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary.
  • Rigo J; First Dept. of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary.
Pregnancy Hypertens ; 2(3): 272, 2012 Jul.
Article em En | MEDLINE | ID: mdl-26105379
ABSTRACT

INTRODUCTION:

Diagnosis of the presence of disease and prediction of the rate of progression of disease in women with hypertensive disorders of pregnancy remains a clinical problem.

OBJECTIVES:

Adequate placentation and placental development are important for normal pregnancy. We determined whether PlGF is a better predictor of delivery before 34+0 and 37+0 weeks than uterine artery and umbilical artery doppler.

METHODS:

One hundred and four women presenting before the completed 34th week of pregnancy with hypertensive disorders of pregnancy were enrolled into the study. Final diagnosis was chronic hypertension (N=24), gestational hypertension (N=21), pre-eclampsia (N=24), HELLP-syndrome (N=15), superimposed preeclampsia (N=20). Blood draw occurred before the 34th week of pregnancy at the time of investigation for expedited delivery or expectant management. Plasma was analysed for PlGF by the Alere Triage® PlGF assay using fluorescently-labelled monoclonal antibodies against PlGF. A positive PlGF test was defined as below the 5th centile of normal healthy pregnancy.

RESULTS:

Of the 104 pregnant women, the level of PlGF was abnormal in 23 of 24 (96%) women with IUGR, compared to 10 of 24 (42%) and 14 of 24 (58%) for uterine artery doppler and umbilical artery doppler, respectively. In the case of pre-eclampsia, the level of PlGF was abnormal in 50 of 59 (85%), compared to 15 of 59 (25%) and 25 of 56 (45%) for uterine artery doppler and umbilical artery doppler, respectively. Forty four (42%) women required medical delivery before 34+0 weeks gestation and 68 (65%) before 37+0 weeks gestation (see Table). PlGF detected a higher number of women requiring early delivery than doppler.

CONCLUSION:

The new Triage® PlGF test provides useful information to inform clinical decisions in pregnancy-associated hypertensive disorders, before the 34th completed gestational week.

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2012 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2012 Tipo de documento: Article